Grail Inc.’s Galleri test doesn’t diagnose cancer but instead, with a single blood draw, looks for a signal that someone might have one of a long list of tumors.

The panelists expressed reservations about the evidence supporting Grail’s Galleri test, which is designed to detect cancers early.